Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature
- B Hervier1,
- C Pagnoux2,
- C Agard1,
- J Haroche3,
- Z Amoura3,
- L Guillevin2,
- M A Hamidou1,
- for the French Vasculitis Study Group
- 1Department of Internal Medicine, CHU Nantes, France
- 2Department of Internal Medicine, Hôpital Cochin, Paris, France
- 3Department of Internal Medicine, CHU Pitié-Salpétrière, Paris, France
- Dr B Hervier, Department of Internal Medicine, CHU Nantes 44093, France; baptiste.hervier{at}chu-nantes.fr
- Accepted 29 September 2008
- Published Online First 28 October 2008
Abstract
Objective: To describe the clinical presentation of the association between pulmonary fibrosis (PF) and systemic vasculitis related to antineutrophil cytoplasmic antibodies (ANCA-V).
Methods: 12 patients (three female, mean age 70.7 years) with ANCA-V associated with “idiopathic” PF were studied retrospectively.
Results: ANCA-V and PF were diagnosed simultaneously in eight cases; PF occurred earlier in three cases and during ANCA-V follow-up in one. No patient had intra-alveolar haemorrhage (IAH). ANCA were myeloperoxidase (MPO)-ANCA in all cases. Seven patients had blood eosinophilia at diagnosis. Two patients died during ANCA-V induction therapy. The respiratory status of five patients worsened and three of them died from exacerbation of end-stage respiratory failure. The five remaining patients had a stable respiratory status.
Conclusion: The association of PF and ANCA-V does not seem to be fortuitous, even though their clinical evolutions are clearly not related. PF was the major cause of death.
Footnotes
-
Competing interests: None.
-
Ethics approval: Ethics committee approval obtained.








